Open AccessAssociation between adjuvant chemotherapy and survival in patients with rectal cancer and pathological complete response after neoadjuvant chemoradiotherapy and resection
Author(s) -
Fang He,
HuaiQiang Ju,
Yi Ding,
Zhiqiang Jiang,
Zhenhui Li,
Bo Huang,
Xiuhong Wang,
Yuanyuan Zhao,
Yong Li,
Bin Qi,
Wei Luo,
Zijian Zhang,
Qian Pei,
Haiyang Chen,
Shuai Liu,
Xiaolin Pang,
Jian Zheng,
Jianping Wang,
Jaffer A. Ajani,
Xiang Wan
Publication year - 2020
Publication title -
british journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.833
H-Index - 236
eISSN - 1532-1827
pISSN - 0007-0920
DOI - 10.1038/s41416-020-0989-1
Subject(s) - medicine , colorectal cancer , propensity score matching , oncology , chemoradiotherapy , neoadjuvant therapy , chemotherapy , survival analysis , subgroup analysis , cancer , gastroenterology , surgery , confidence interval , breast cancer
For patients with locally advanced rectal cancer (LARC), it is unclear whether neoadjuvant chemoradiotherapy-induced pathologic complete response (pCR) individuals would further benefit from adjuvant chemotherapy (ACT).